uniQure
QURE
#5873
Rank
A$1.57 B
Marketcap
A$25.12
Share price
0.19%
Change (1 day)
14.78%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -A$0.36 Billion

According to uniQure's latest financial reports the company's current earnings are A$15.75 Million. In 2024 the company made an earning of -A$0.33 Billion, an increase over its 2023 earnings that were of -A$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.36 Billion6.46%
2024 -A$0.33 Billion-22.65%
2023 -A$0.43 Billion139.01%
2022 -A$0.18 Billion-138.54%
2021 A$0.46 B-335.29%
2020 -A$0.2 Billion13.88%
2019 -A$0.18 Billion49.51%
2018 -A$0.12 Billion4.55%
2017 -A$0.12 Billion12.65%
2016 -A$98.08 Million-9.59%
2015 -A$0.11 Billion66.95%
2014 -A$64.98 Million30.8%
2013 -A$49.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.48 B-4,093.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.70 B-3,525.82%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-A$0.16 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-A$0.28 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.67 B-314.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-A$0.96 Billion 204.63%๐Ÿ‡บ๐Ÿ‡ธ USA